يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Zorko N."', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
    دورية أكاديمية
    755P B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through NK cells.

    المؤلفون: Miller, J.S.1 (AUTHOR), Zorko, N.1 (AUTHOR), Merino, A.1 (AUTHOR), Phung, G.1 (AUTHOR), Khaw, M.1 (AUTHOR), Howard, P.1 (AUTHOR), Hamsher, H.1 (AUTHOR), Davis, Z.1 (AUTHOR), Cichocki, F.1 (AUTHOR), Berk, G.I.2 (AUTHOR), Felices, M.1 (AUTHOR)

    المصدر: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS889-S889. 1p.

    مصطلحات موضوعية: *KILLER cells, *TUMOR antigens, *T cells

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    126P Novel B7-H3 targeting dual nanobody NK cell engagers display robust activity against a broad spectrum of solid and hematologic malignancies.

    المؤلفون: Zorko, N.1 (AUTHOR), Felices, M.2 (AUTHOR), Merino, A.1 (AUTHOR), Walker, J.2 (AUTHOR), Kodal, B.2 (AUTHOR), Lenvik, A.2 (AUTHOR), Davis, Z.B.2 (AUTHOR), Lenvik, T.2 (AUTHOR), Tape, S.2 (AUTHOR), Soignier, Y.2 (AUTHOR), Nelson, T.2 (AUTHOR), Hinderlie, P.2 (AUTHOR), Antonarakis, E.2 (AUTHOR), Cichocki, F.2 (AUTHOR), Hwang, J.2 (AUTHOR), Berk, G.3 (AUTHOR), Miller, J.S.2 (AUTHOR)

    المصدر: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1433-S1433. 1p.

    مصطلحات موضوعية: *KILLER cells, *HEMATOLOGIC malignancies

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.

    المؤلفون: Bernot, K M1, Siebenaler, R F1, Whitman, S P1, Zorko, N A1, Marcucci, G G1, Santhanam, R1, Ahmed, E H1, Ngangana, M1, McConnell, K K1, Nemer, J S1, Brook, D L1, Kulp, S K2, Chen, C S2, Frankhouser, D3, Yan, P3, Bundschuh, R4, Zhang, X5, Dorrance, A M1, Dickerson, K E6, Jarjoura, D5

    المصدر: Leukemia (08876924). Dec2013, Vol. 27 Issue 12, p2379-2382. 4p.

    مصطلحات موضوعية: *ACUTE myeloid leukemia, *CYTOGENETICS

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    965MO GTB-3550 tri-specific killer engager safely activates and delivers IL-15 to NK cells, but not T-cells, in immune suppressed patients with advanced myeloid malignancies, a novel paradigm exportable to solid tumors expressing Her2 or B7H3.

    المؤلفون: Miller, J.S.1 (AUTHOR), Warlick, E.D.1 (AUTHOR), Wangen, R.2 (AUTHOR), Zorko, N.3 (AUTHOR), Hinderlie, P.1 (AUTHOR), Lewis, D.1 (AUTHOR), Vallera, D.A.4 (AUTHOR), Felices, M.1 (AUTHOR)

    المصدر: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS834-S834. 1p.

    مصطلحات موضوعية: *KILLER cells, *T cells, *TUMORS

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث